Constructing health state preference values from descriptive quality of life outcomes: Mission impossible?
- 1 January 1997
- journal article
- Published by Springer Science and Business Media LLC in Quality of Life Research
- Vol. 6 (2), 159-68
- https://doi.org/10.1023/a:1026494218030
Abstract
Descriptive quality of life questionnaires are commonly administered in clinical trials, to evaluate outcomes from the patient's perspective alongside conventional clinical measures. When expressed in single index form as health state preference values (HSPVs), quality of life information is also relevant to economic evaluations. By combining HSPVs with survival information, quality adjusted life years (QALYs) may be derived for cost-utility analysis. Although HSPVs are rarely measured prospectively in cancer clinical trials, the UK Medical Research Council Cancer Therapy Committee recommends the routine administration of two specific quality of life questionnaires: the Rotterdam Symptom Checklist and the Hospital Anxiety Depression Scale. This study explores two potential methods for secondary derivation of HSPVs from these instruments, using data gathered in a clinical trial of two forms of radiotherapy for non-small cell cancer of the bronchus. The first method, secondary mapping to existing utility scales, was found to be infeasible from the above questionnaires. The second method used factor analysis to summarize the descriptive quality of life data collected through the questionnaires. This revealed five distinct factors prevalent in the trial population. Using these factors, simplified health state scenarios were developed from which direct measurement of HSPVs was feasible. As the resulting HSPVs and any QALYs that may be derived from them are cancer specific, their potential value in informing resource allocation would be limited to decisions within oncology services.Keywords
This publication has 17 references indexed in Scilit:
- Framing and labelling effects in health descriptions: Quality adjusted life years for treatment of breast cancerJournal of Clinical Epidemiology, 1993
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Quality of life assessment during chemotherapy for non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Preliminary experience with quality of life evaluation in patients with lung cancer.1990
- Assessing quality of life in cancer patientsBritish Journal of Cancer, 1989
- Quality of Life of Lung Cancer Patients in a Randomized Clinical Trial Evaluated by a Psychosocial Well-Being QuestionnaireActa Oncologica, 1988
- Who should measure quality of life, the doctor or the patient?British Journal of Cancer, 1988
- The quality of life of cancer patients: A review of the literatureSocial Science & Medicine (1982), 1985
- Economics of coronary artery bypass grafting.BMJ, 1985
- Describing health states. Methodologic issues in obtaining values for health states.1984